P304
Reprogramming of the protein phosphatase 1 interactome during heart failure progression

Cardiovascular Research

23 April 2018

Organised by:

Read full article

Contributors

AJR Heck

AJR Heck

Author

XHT Wehrens

XHT Wehrens

Author

D Y Chiang

D Y Chiang

Author

K M Alsina

K M Alsina

Author

E Corradini

E Corradini

Author

M Fitzpatrick

M Fitzpatrick

Author

L Ni

L Ni

Author

J Reynolds

J Reynolds

Author

S K Lahiri

S K Lahiri

Author

L Scott

L Scott

Author

You may be interested in

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

17 May 2025

Congress Presentation

Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete reverse remodelling after aortic valve replacement

20 May 2023

Congress Presentation

Role of PTP1B/Ptpn1 and TCPTP/Ptpn2 in sepsis-induced cardiomyopathy

1 September 2025

Congress Presentation

Myeloperoxidase inhibition reverses the inflammatory proteomic pattern in heart failure with preserved ejection fraction

1 July 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources